Asia-pacific Ophthalmic Drugs Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	141 Pages	Triton Market Research	April, 2024	TRTN18748631

Best Price Guarantee
Price	from $1,500
Length	141 Pages
Publisher	Triton Market Research
Published Date	April, 2024
SKU	TRTN18748631

Asia-pacific Ophthalmic Drugs Market 2023-2030

Market Outlook

Triton’s research report shows that the Asia-Pacific ophthalmic drugs market is expected to achieve revenue growth at a CAGR of 7.56% during the 2023-2030 forecast years. Japan, India, South Korea, Australia & New Zealand, China, ASEAN countries, and the Rest of Asia-Pacific are examined in this report.

The rapidly aging population in Japan marks it as the regional leader in the field of ophthalmology. The demographic shift due to an increase in the elderly population creates a high prevalence of age-related eye disorders. In order to treat and cure cataracts, glaucoma, and age-related macular degeneration (AMD), the demand for ophthalmic drugs is rising. Additionally, the health care system in Japan provides exceptional eye care to patients with innovative and advanced solutions, which has significant scope to boost the ophthalmic drugs market.

Similarly, India is witnessing a significant rise in eye disorders across all ages due to changing lifestyles and increased screen time. The expansion in health infrastructure to make eye care clinics and hospitals accessible to everyone will create a demand for ophthalmic drugs. Along with that, the pharmaceutical innovations in developing preservative eye drops and therapies will also drive market growth in the coming years.

Competitive Outlook

The key companies listed in the ophthalmic drugs market are AbbVie Inc, Bausch Health Companies Inc, Accutome Inc, Genentech Inc, Thea Pharma Inc, and Johnson & Johnson.

1. Asia-pacific Ophthalmic Drugs Market - Summary
2. Industry Outlook: 2.1. Technology Snapshot; 2.2. Impact Analysis On The Ophthalmic Drugs Market; 2.2.1. Covid-19 Impact On The Ophthalmic Drugs Market; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Maturity Analysis; 2.5. Regulatory Framework; 2.6. Key Buying Impact Analysis; 2.7. Key Market Strategies; 2.7.1. Collaborations; 2.7.2. Product Launches; 2.7.3. Mergers & Acquisitions; 2.8. Market Drivers; 2.8.1. Aging Population Vulnerable To Eye Disorders; 2.8.2. Progress In Drug Delivery Technologies; 2.8.3. Escalating Incidence Of Ocular Diseases; 2.8.4. Reimbursement Policies By Healthcare Systems; 2.9. Market Challenges; 2.9.1. Challenging Timelines For Product Approval; 2.9.2. Adverse Effects Associated With Ophthalmic Drug Usage; 2.10. Market Opportunities; 2.10.1. Surge In Interest Regarding Topically Administered Ophthalmic Drugs; 2.10.2. Increase In Approvals For Innovative Ophthalmic Therapies; 2.11. Analyst Perspective
3. Asia-pacific Ophthalmic Drugs Market – By Type: 3.1. Prescription Drugs; 3.2. Over-the-counter Drugs
4. Asia-pacific Ophthalmic Drugs Market – By Condition: 4.1. Dry Eye; 4.2. Glaucoma; 4.3. Infection/Inflammation/Allergies; 4.4. Retinal Disorder; 4.4.1. Wet-age Related Macular Degeneration; 4.4.2. Dry-age Related Macular Degeneration; 4.4.3. Diabetic Retinopathy; 4.4.4. Other Retinal Disorders; 4.5. Other Conditions
5. Asia-pacific Ophthalmic Drugs Market – By Therapeutic Type: 5.1. Anti-glaucoma; 5.2. Anti-infection; 5.3. Anti-inflammatory; 5.4. Anti-allergy; 5.5. Other Therapeutic Types
6. Asia-pacific Ophthalmic Drugs Market – By Delivery Method: 6.1. Gels; 6.2. Eye Solutions & Suspensions; 6.3. Capsules & Tablets; 6.4. Eye Drops; 6.5. Ointments
7. Asia-pacific Ophthalmic Drugs Market – By Channel: 7.1. Hospital Pharmacies; 7.2. Drug Stores; 7.3. Online Pharmacies; 7.4. Other Channels
8. Asia-pacific Ophthalmic Drugs Market – Country Outlook: 8.1. China; 8.1.1. China Ophthalmic Drugs Market Forecast & Prospects; 8.2. Japan; 8.2.1. Japan Ophthalmic Drugs Market Forecast & Prospects; 8.3. India; 8.3.1. India Ophthalmic Drugs Market Forecast & Prospects; 8.4. South Korea; 8.4.1. South Korea Ophthalmic Drugs Market Forecast & Prospects; 8.5. Asean Countries; 8.5.1. Asean Countries Ophthalmic Drugs Market Forecast & Prospects; 8.6. Australia & New Zealand; 8.6.1. Australia & New Zealand Ophthalmic Drugs Market Forecast & Prospects; 8.7. Rest Of Asia-pacific; 8.7.1. Rest Of Asia-pacific Ophthalmic Drugs Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abbvie Inc; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.1.3. Key Strengths; 9.1.4. Key Challenges; 9.2. Bausch Health Companies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Johnson & Johnson; 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Novartis Ag; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Regeneron Pharmaceuticals Inc; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.5.3. Key Strengths; 9.5.4. Key Challenges; 9.6. Sun Pharmaceutical Industries Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Accutome Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Genentech Inc; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.8.3. Key Strengths; 9.8.4. Key Challenges; 9.9. Thea Pharma Inc; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.9.3. Key Strengths; 9.9.4. Key Challenges; 9.10. Pfizer Inc; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
Tables List: Table 1: Asia-pacific Ophthalmic Drugs Market, By Country, 2023-2030 (In $ Million); Table 2: Regulatory Framework; Table 3: List Of Collaborations; Table 4: List Of Product Launches; Table 5: List Of Mergers & Acquisitions; Table 6: Asia-pacific Ophthalmic Drugs Market, By Country Outlook, 2023-2030 (In $ Million); Table 7: Asia-pacific Ophthalmic Drugs Market, By Type, 2023-2030 (In $ Million); Table 8: Asia-pacific Ophthalmic Drugs Market, By Condition, 2023-2030 (In $ Million); Table 9: Asia-pacific Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Table 10: Asia-pacific Ophthalmic Drugs Market, By Therapeutic Type, 2023-2030 (In $ Million); Table 11: Asia-pacific Ophthalmic Drugs Market, By Delivery Method, 2023-2030 (In $ Million); Table 12: Asia-pacific Ophthalmic Drugs Market, By Channel, 2023-2030 (In $ Million)
Figures List: Figure 1: Technology Snapshot; Figure 2: Market Maturity Analysis; Figure 3: Asia-pacific Ophthalmic Drugs Market, By Type, 2022 & 2030 (In %); Figure 4: Asia-pacific Ophthalmic Drugs Market, By Prescription Drugs, 2023-2030 (In $ Million); Figure 5: Asia-pacific Ophthalmic Drugs Market, By Over-the-counter Drugs, 2023-2030 (In $ Million); Figure 6: Asia-pacific Ophthalmic Drugs Market, By Condition, 2022 & 2030 (In %); Figure 7: Asia-pacific Ophthalmic Drugs Market, By Dry Eye, 2023-2030 (In $ Million); Figure 8: Asia-pacific Ophthalmic Drugs Market, By Glaucoma, 2023-2030 (In $ Million); Figure 9: Asia-pacific Ophthalmic Drugs Market, By Infection/Inflammation/Allergies, 2023-2030 (In $ Million); Figure 10: Asia-pacific Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Figure 11: Asia-pacific Ophthalmic Drugs Market, By Retinal Disorder, 2022 & 2030 (In %); Figure 12: Asia-pacific Ophthalmic Drugs Market, By Wet Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 13: Asia-pacific Ophthalmic Drugs Market, By Dry Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 14: Asia-pacific Ophthalmic Drugs Market, By Diabetic Retinopathy, 2023-2030 (In $ Million); Figure 15: Asia-pacific Ophthalmic Drugs Market, By Other Retinal Disorders, 2023-2030 (In $ Million); Figure 16: Asia-pacific Ophthalmic Drugs Market, By Other Conditions, 2023-2030 (In $ Million); Figure 17: Asia-pacific Ophthalmic Drugs Market, By Therapeutic Type, 2022 & 2030 (In %); Figure 18: Asia-pacific Ophthalmic Drugs Market, By Anti-glaucoma, 2023-2030 (In $ Million); Figure 19: Asia-pacific Ophthalmic Drugs Market, By Anti-infection, 2023-2030 (In $ Million); Figure 20: Asia-pacific Ophthalmic Drugs Market, By Anti-inflammatory, 2023-2030 (In $ Million); Figure 21: Asia-pacific Ophthalmic Drugs Market, By Anti-allergy, 2023-2030 (In $ Million); Figure 22: Asia-pacific Ophthalmic Drugs Market, By Other Therapeutic Types, 2023-2030 (In $ Million); Figure 23: Asia-pacific Ophthalmic Drugs Market, By Delivery Method, 2022 & 2030 (In %); Figure 24: Asia-pacific Ophthalmic Drugs Market, By Gels, 2023-2030 (In $ Million); Figure 25: Asia-pacific Ophthalmic Drugs Market, By Eye Solutions & Suspensions, 2023-2030 (In $ Million); Figure 26: Asia-pacific Ophthalmic Drugs Market, By Capsules & Tablets, 2023-2030 (In $ Million); Figure 27: Asia-pacific Ophthalmic Drugs Market, By Eye Drops, 2023-2030 (In $ Million); Figure 28: Asia-pacific Ophthalmic Drugs Market, By Ointments, 2023-2030 (In $ Million); Figure 29: Asia-pacific Ophthalmic Drugs Market, By Channel, 2022 & 2030 (In %); Figure 30: Asia-pacific Ophthalmic Drugs Market, By Hospital Pharmacies, 2023-2030 (In $ Million); Figure 31: Asia-pacific Ophthalmic Drugs Market, By Drug Stores, 2023-2030 (In $ Million); Figure 32: Asia-pacific Ophthalmic Drugs Market, By Online Pharmacies, 2023-2030 (In $ Million); Figure 33: Asia-pacific Ophthalmic Drugs Market, By Other Channels, 2023-2030 (In $ Million); Figure 34: Asia-pacific Ophthalmic Drugs Market, By Country Outlook, 2022 & 2030 (In %); Figure 35: China Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 36: Japan Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 37: India Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 38: South Korea Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 39: Asean Countries Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 40: Australia & New Zealand Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 41: Rest Of Asia-pacific Ophthalmic Drugs Market, 2023-2030 (In $ Million)